Task: Answer the MCQ question.
Question: Which drug exhibits a -22.877% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. O=C(CCn1c(=S)[nH]c2ccccc2c1=O)NCCCN1CCCC1=O
b. COc1ccccc1NC(=O)CN1C(=O)COc2ccc(S(=O)(=O)N3CCC(C)CC3)cc21
Answer: a. O=C(CCn1c(=S)[nH]c2ccccc2c1=O)NCCCN1CCCC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCn1c(=S)[nH]c2ccccc2c1=O)NCCCN1CCCC1=O
O=C(CCn1c(=S)[nH]c2ccccc2c1=O)NCCCN1CCCC1=O
N-[3-(2-oxopyrrolidin-1-yl)propyl]-3-(4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)propanamide